Search

everythinglearnresearchcommunity

for

Search:↓

Silver nanoparticles from Mitracarpus scaber protect the liver and reduce prostate enlargement.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

A woman with type 2 diabetes developed alopecia areata, suggesting a link between the two autoimmune conditions.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Finasteride works better for hair loss in patients 26 or younger.

Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Higher PSA levels are linked to more hirsutism in women with PCOS.

Shorter PSADT after prostate surgery is linked to higher risk of death.

Low dose finasteride causes only small changes in PSA levels in older men with BPH.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Olive leaves extract may help treat benign prostatic hyperplasia (BPH).

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Finasteride reduces low-grade prostate cancer but may not be beneficial overall.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Long-term finasteride use may lead to earlier use of ED medication and lower prostate cancer diagnosis rates.